# Salvage Chemotherapy Versus Total Mesorectal Resection for Local Resection Rectal Cancer Patients

> **NCT06043999** · NA · RECRUITING · sponsor: **Sun Yat-sen University** · enrollment: 392 (estimated)

## Conditions studied

- Chemotherapy Effect
- Rectal Cancer

## Interventions

- **PROCEDURE:** Radical total mesorectal excision
- **OTHER:** Salavge Adjuvant Chemoradiotherapy

## Key facts

- **NCT ID:** NCT06043999
- **Lead sponsor:** Sun Yat-sen University
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2023-09-01
- **Primary completion:** 2028-12-31
- **Final completion:** 2028-12-31
- **Target enrollment:** 392 (ESTIMATED)
- **Last updated:** 2023-09-21


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06043999

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06043999, "Salvage Chemotherapy Versus Total Mesorectal Resection for Local Resection Rectal Cancer Patients". Retrieved via AI Analytics 2026-06-09 from https://api.ai-analytics.org/clinical/NCT06043999. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*